Age of AI Europe, 2025
March 4, 2025 · London, England
#1 Gen AI event for Healthcare Marketing and Communications
Ana Cerdeira, Ph.D.
VP, Global Head Commercial, Development Assets, Innovative Medicines Group · Grünenthal
Ana Cerdeira, Ph.D.
VP, Global Head Commercial, Development Assets, Innovative Medicines Group
Grünenthal
Ana Cerdeira, Ph.D., VP, Global Head Commercial, Development Assets, Innovative Medicines Group, Grunenthal Group- Ana brings almost two decades of experience in global business development and strategic portfolio management. Prior to joining Grünenthal, Ana held several leadership positions at Molecular Partners as VP Strategic Planning and Portfolio Management and at Takeda Pharmaceuticals, as VP of Emerging Markets Portfolio Management. Previously, Ana held several positions at Janssen Pharmaceuticals, including CMC Drug Product Leader. She earned a MPharm from the University of Lisbon, Portugal and a Ph.D. from Eidgenössische Technische Hochschule Zürich (ETH Zürich), Switzerland.
Sessions
Dr. Will McCully
4:30 PM – 5:00 PM
Panel: Industry’s leading experts unveil their top goals for generative AI to support HCPs and patients.
- Industry leaders will share their strategic focus for 2025 and beyond, emphasizing AI-driven efficiency, personalization & the digital innovations being embedded across the organization.
Dr. Will McCully, Co-founder & Director, AITHENA
Uday Bose MBA, MSc, BSc Econ (HONS), Head of Human Pharma Global Customer Experience Excellence (CXE) and Business Steering, Boehringer Ingelheim
Ana Cerdeira, Ph.D., VP, Global Head Commercial, Development Assets, Innovative Medicines Group, Grünenthal
Patricio Múrias dos Santos, Executive Director, Global Marketing, PTC Theraputics
Panel Discussion